To determine what harm reduction services are being offered by rural pharmacies in 7 states.

In this study, listeners are asked to wear headphones or listen to sounds through a computer and make decisions about what they hear or see. We are interested in how listeners with normal hearing and hearing loss understand speech and access language.

Randomized trial testing treatment of ulcerative pyoderma gangrenosum

To evaluate safety and efficacy of therapeutic vaccination with chimpanzee adenovirus (ChAdV)- and poxvirus modified vaccinia Ankara (MVA)-vectored vaccines in a sequential regimen with the Toll-like Receptor 7 (TLR7) agonist vesatolimod (VES) and two broadly neutralizing antibodies (bNAbs) in individuals with HIV-1 who started suppressive antiretroviral therapy (ART) during acute HIV-1.

Analyze biospecimens and conduct analyses on the association between endocrine disrupting chemicals and child neurodevelopment and growth.

This study is comparing two ways of treating Atrial Fibrillation (AF). Patients will either take continuous anticoagulation medications, or they will wear AF-sensing smartwatches and take anticoagulation medications for 30 days after an AF event.

The purpose of the study is to determine if information about how public housing programs can increase recipient insecurity, and how information about this insecurity can contribute to a reduction in support for social policy among the general population.

The purpose of this study is to optimize social media messages to encourage people to connect with others. Our goal is to create messages that resonate with populations that face a higher burden of disease.

Sanfilippo syndrome Type A or mucopolysaccharidosis type IIIA (MPS IIIA) is a rare genetic disorder caused by the deficiency of the lysosomal enzyme sulfamidase. Lack of this enzyme causes buildup of large sugar molecules called glycosaminoglycans (GAGs) in the lysosomes which leads to cellular dysfunction. The buildup of GAGs causes significant damage to the body and brain. This study is a multicenter, Phase 1/2 study to assess the safety, tolerability, and efficacy of they study drug DNL126, an enzyme replacement therapy, to provide the missing enzyme to the body. Up to 28 participants with MPS IIIA will participate in the study across multiple study sites .

To determine the helpfulness of using images of brain anatomy to educate patients about their cognitive disorders.